首页> 外文期刊>Tropical biomedicine. >Clinical and laboratory diagnosis of contagious caprine pleuropneumonia in Qassim region, Saudi Arabia: a comparative study
【24h】

Clinical and laboratory diagnosis of contagious caprine pleuropneumonia in Qassim region, Saudi Arabia: a comparative study

机译:沙特阿拉伯QASSIM地区传染群胸膜炎患者的临床和实验室诊断:比较研究

获取原文
           

摘要

Diagnosis of contagious caprine pleuropneumonia (CCPP) in Saudi Arabia mainly depends on clinical signs and post-mortem findings, in addition to limited usage of latex agglutination test (LAT). In this study, a PCR method specific for detection of Mycoplasma capricolum subspecies capripneumoniae (Mccp) was used as a direct confirmatory method and to compare it with clinical signs, necropsy lesions and LAT. During the 2016-2017 year, samples of serum, pleural fluid, lung tissue and nasal swab were collected from 40 goats with clinical signs of CCPP, which were selected from goats brought to the veterinary clinic of Qassim University from 18 goat herds and nine localities. Epidemiological data revealed 34.1%, 27.8% and 81.6% morbidity, mortality and case fatality rates, respectively. At necropsy, 31 of 40 goats (77.5%) were found with lesions matching those of CCPP. Molecular findings supported the suitability and applicability of PCR as a reliable method to diagnose and confirm CCPP directly from clinical samples. The disease was confirmed by PCR in 35 goats out of 40 (87.5%), 15 herds out of 18 (83.3%) and in all localities. Sera of 32 goats (80%) were found positive by LAT. Four of the five goats and two of the three herds negative by PCR were also negative by LAT and necropsy examination. Therefore, PCR sensitivity was considered 97.2% (35/36). Compared to the claimed high specificity and sensitivity of the used PCR method, diagnosis of CCPP based on clinical signs was found less specific and necropsy examination and LAT were less sensitive. It was concluded that molecular detection of Mccp directly in clinical samples should routinely be used to confirm diagnosis of CCPP in the region of study, prevent economic impact of wrong diagnosis and to hasten control process.
机译:沙特阿拉伯的传染症胸膜胸膜炎(CCPP)的诊断主要取决于临床症状和验尸后发现,除了有限的乳胶凝集试验(LAT)。在该研究中,使用特异性用于检测岩浆菌亚种的PCR方法Capripneumoniae(MCCP)作为直接验证方法,并将其与临床症状,尸检病变和拉特进行比较。在2016-2017年期间,从40名山羊收集了血清,胸膜液,肺组织和鼻拭子的样本,其中CCPP的临床症状,从18座山羊群和九个地方选择了从古斯克斯大学的兽医诊所所选的山羊。流行病学数据分别显示出30.1%,27.8%和81.6%的发病率,死亡率和病例率分别。在尸检时,发现40只山羊(77.5%),病变与CCPP那些匹配。分子发现支持PCR作为可靠的方法,可直接从临床样品诊断和确认CCPP的可靠方法。该疾病通过PCR在35只(87.5%)中的35只(87.5%),其中15只(83.3%)和所有地区。 32只山羊血清(80%)被拉特发现阳性。 PCR的五只山羊中的四只山羊和两只牧群中的两只阴性也是消极的,受到LAT和尸检的检查。因此,PCR敏感性被认为是97.2%(35/36)。与所要求保护的PCR方法的高特异性和敏感性相比,基于临床症状的CCPP诊断发现较少的特异性和尸检检查,LAT敏感性较小。得出结论是,直接在临床样品中的MCCP的分子检测应常常用于确诊在研究区域中CCPP的诊断,防止错误的诊断和加速控制过程的经济影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号